The Times Australia
The Times Australia

.

Why doesn’t Australia make more medicines? Wouldn’t that fix drug shortages?

  • Written by Peter Coomber, PhD Candidate, Pharmaceutical Supply Chains, The University of Queensland

About 400 medicines[1] are in short supply in Australia. Of these, about 30 are categorised as critical[2]. These are ones with a life-threatening or serious impact on patients, and with no readily available substitutes.

Since 2024, there has been a nationwide shortage of sterile fluid[3]. This continues to affect[4] health care across Australia.

However, medicine shortages in Australia are not new. We know from past experience that six classes of medications[5] are the most likely to go short: antibiotics, anaesthesia and pain relief treatments, heart and blood pressure medications, hormonal medications, cancer treatments and epilepsy medications.

So, could we prevent medication shortages if Australia made more medicines[6]?

Why are there so many shortages?

Australia has a very small[7] pharmaceutical manufacturing industry. It mainly makes[8] vaccines and some generic medications (ones no longer protected by a patent). In fact, Australia imports 90%[9] of its medications[10].

Most raw ingredients are also imported, including the active pharmaceutical ingredient[11]. This is the ingredient that has a therapeutic effect, such as salbutamol to manage asthma or atorvastatin to lower cholesterol. Australia also imports the inactive ingredients known as excipients[12]. These include fillers, bulking agents and preservatives.

Then there are medication delivery devices (such as inhalers or syringes) and packaging (which has to be sterile) to source.

A shortage in one ingredient or component – in Australia or internationally – will affect the production and supply of the finished product. This can lead to shortages.

Often, there are limited sources (or a single source) for medication components. This makes supply chains[13] particularly vulnerable[14].

Australia is a small player, globally

Australia is a small market for pharmaceuticals[15], compared with other OECD countries.

So during a shortage of medications, raw materials or other components, suppliers prioritise larger and therefore more valuable markets.

Australia’s Pharmaceutical Benefits Scheme (PBS) has an underpinning pricing mechanism[16] to provide affordable medicines for Australians. But this also makes the market less attractive[17] to medication manufacturers.

Therefore, countries where markets are bigger, and offer larger profit margins, are more attractive. This restricts the type and range of medications offered to the Australian market, including when supplies are short.

Ampules of medicine on production line
Australia needs medicines, raw ingredients and sterile packaging, all of which can be in short supply. RGtimeline/Shutterstock[18]

So could ramping up local manufacture help?

The answer is maybe.

But developing Australia’s limited pharmaceutical manufacturing would take many years to reach a level and capacity for sustainable supply.

Increasing local manufacturing would address access to some medicines. However, domestic manufacturers also need access to raw ingredients. These could also be made locally.

For pharmaceutical manufacturing to be viable and profitable[19] in Australia there must be “economies of scale”.

Considerations include the availability of raw materials, production costs (including labour), access and availability of infrastructure and specialist facilities. To justify their investments, companies will ultimately need to sell enough product to cover these and other costs.

But Australian manufacturers struggle to achieve economies of scale due to the small domestic market. So they would need to export some of their products to supplement domestic sales.

To boost Australia’s pharmaceutical manufacturing industry, all states and territories would need a coordinated approach to planning and investment. This would also need bipartisan political support and a strategic long-term commitment.

What could we do in the short term?

Health authorities stockpiling medicines is the obvious short-term solution to Australian medication shortages. However, we’d need to carefully manage the stored medicines to ensure supply meets demand. We’d also need to make sure medicines are used before they expire. If not carefully managed, a stockpile risks unnecessary expense and waste.

Currently, state and territories manage the use of medications in their own hospitals. However, we could standardise medication use in hospitals nationally. With co-operation among states and territories this would allow manufacturers and suppliers to better plan production and distribution of medicines. Not only would this provide more certainty for suppliers, it would reduce the states and territories competing with each other for medicines in short supply.

We also need to review the pricing mechanism for medicines to make the Australian market more attractive for pharmaceutical imports. This would also help Australia move higher up the priority list when medicines are in short supply.

References

  1. ^ 400 medicines (apps.tga.gov.au)
  2. ^ about 30 are categorised as critical (apps.tga.gov.au)
  3. ^ shortage of sterile fluid (theconversation.com)
  4. ^ continues to affect (www.tga.gov.au)
  5. ^ six classes of medications (adpha.au)
  6. ^ made more medicines (ajp.com.au)
  7. ^ very small (www1.racgp.org.au)
  8. ^ mainly makes (www.medicinesaustralia.com.au)
  9. ^ imports 90% (sldinfo.com)
  10. ^ of its medications (parlinfo.aph.gov.au)
  11. ^ active pharmaceutical ingredient (www.cancer.gov)
  12. ^ inactive ingredients known as excipients (australianprescriber.tg.org.au)
  13. ^ supply chains (www.medicinesaustralia.com.au)
  14. ^ particularly vulnerable (ajp.com.au)
  15. ^ small market for pharmaceuticals (www.medicinesaustralia.com.au)
  16. ^ underpinning pricing mechanism (www.pbs.gov.au)
  17. ^ less attractive (theconversation.com)
  18. ^ RGtimeline/Shutterstock (www.shutterstock.com)
  19. ^ viable and profitable (www.medicinesaustralia.com.au)

Read more https://theconversation.com/why-doesnt-australia-make-more-medicines-wouldnt-that-fix-drug-shortages-255766

Extreme weather could send milk prices soaring, deepening challenges for the dairy industry

Australia’s dairy industry is in the middle of a crisis, fuelled by an almost perfect storm of challenges. ...

Times Magazine

From Beach Bops to Alpine Anthems: Your Sonos Survival Guide for a Long Weekend Escape

Alright, fellow adventurers and relaxation enthusiasts! So, you've packed your bags, charged your devices, and mentally prepared for that glorious King's Birthday long weekend. But hold on, are you really ready? Because a true long weekend warrior kn...

Effective Commercial Pest Control Solutions for a Safer Workplace

Keeping a workplace clean, safe, and free from pests is essential for maintaining productivity, protecting employee health, and upholding a company's reputation. Pests pose health risks, can cause structural damage, and can lead to serious legal an...

The Science Behind Reverse Osmosis and Why It Matters

What is reverse osmosis? Reverse osmosis (RO) is a water purification process that removes contaminants by forcing water through a semi-permeable membrane. This membrane allows only water molecules to pass through while blocking impurities such as...

Foodbank Queensland celebrates local hero for National Volunteer Week

Stephen Carey is a bit bananas.   He splits his time between his insurance broker business, caring for his young family, and volunteering for Foodbank Queensland one day a week. He’s even run the Bridge to Brisbane in a banana suit to raise mon...

Senior of the Year Nominations Open

The Allan Labor Government is encouraging all Victorians to recognise the valuable contributions of older members of our community by nominating them for the 2025 Victorian Senior of the Year Awards.  Minister for Ageing Ingrid Stitt today annou...

CNC Machining Meets Stage Design - Black Swan State Theatre Company & Tommotek

When artistry meets precision engineering, incredible things happen. That’s exactly what unfolded when Tommotek worked alongside the Black Swan State Theatre Company on several of their innovative stage productions. With tight deadlines and intrica...

The Times Features

Cult Favourite, TokyoTaco, Opens Beachfront at Mooloolaba this June

FREE Tokyo Tacos to Celebrate!  Cult favourite Japanese-Mexican restaurant TokyoTaco is opening a beachfront venue at the Mooloolaba Esplanade on Queensland’s Sunshine Coast t...

Samsara Eco and lululemon announce 10 year partnership

lululemon and Samsara Eco Announce 10-Year Plan to Advance Recycled Material Portfolio Plan will see lululemon source a significant portion of its future nylon 6,6 and polyes...

The viral diet that could boost your immunity during winter

As we settle into the winter months, immune health becomes top of mind, and the latest food trend gaining traction may be worth taking seriously, especially when it comes to st...

Running Across Australia: What Really Holds the Body Together?

How William Goodge’s 3,800km run reveals the connection between movement, mindset, and mental resilience As a business owner, I’ve come to realise that the biggest wins rarely com...

Telehealth is Transforming Healthcare Services in Australia

It has traditionally not been easy to access timely healthcare in Australia, particularly for people who live in remote areas. Many of them spend hours on the road just to see...

Launchd Acquires Huume, Strengthening Creative Firepower Across Talent-Led Marketing

Launchd, a leader in talent, technology and brand partnerships, has announced its acquisition of influencer talent management agency Huume from IZEA. The move comes as the medi...